Toxicoproteomics in liver injury and inflammation

Annals of the New York Academy of Sciences

Volumn 1076, Issue , 2006, Pages 707-717

  Merrick, B Alex ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Biomarkers; Environmental toxicity; Liver; Proteomics; Tissue injury; Toxicoproteomics

Indexed keywords

BIOLOGICAL MARKER;

BIOLOGICAL ACTIVITY; BODY FLUID; CONFERENCE PAPER; ENVIRONMENTAL DISEASE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL STRESS; GENE MAPPING; HEPATITIS; HUMAN; LIVER; LIVER INJURY; MOLECULAR BIOLOGY; PLASMA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; SERUM; TARGET ORGAN; TISSUE INJURY; TOXICITY; TOXICOPROTEOMICS; TRANSCRIPTOMICS;

EID: 33845635192     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1371.017     Document Type: Conference Paper

References (23)

1. WATERS, M.D., K. OLDEN & R.W. TENNANT. 2003. Toxicogenomic approach for assessing toxicant-related disease. Mutat. Res. 544: 415-424.
2. PENNISI, E. 2003. Human genome. A low number wins the GeneSweep Pool. Science 300: 1484.
3. MERRICK, B.A. & M.E. BRUNO. 2004. Genomic and proteomic profiling for biomarkers and signature profiles of toxicity. Curr. Opin. Mol. Ther. 6: 600-607.
4. KREMER, A., R. SCHNEIDER & G.C. TERSTAPPEN. 2005. A bioinformatics perspective on proteomics: data storage, analysis, and integration. Biosci. Rep. 25: 95-106.
5. BLUEGGEL, M., D. CHAMRAD & H.E. MEYER. 2004. Bioinformatics in proteomics. Curr. Pharm. Biotechnol. 5: 79-88.
6. WETMORE, B.A. & B.A. MERRICK. 2004. Toxicoproteomics: proteomics applied to toxicology and pathology. Toxicol. Pathol. 32: 619-642.
7. RIGHETTI, P.G., A. CASTAGNA, F. ANTONUCCI, et al. 2004. Critical survey of quantitative proteomics in two-dimensional electrophoretic approaches. J. Chromatogr. A. 1051: 3-17.
8. YATES, J.R. 2004. Mass spectral analysis in proteomics. Annu. Rev. Biophys. Biomol. Struct. 33: 297-316.
9. MACDONALD, N., S. CHEVALIER, R. TONGE, et al. 2001. Quantitative proteomic analysis of mouse liver response to the peroxisome proliferator diethylhexylphthalate (DEHP). Arch. Toxicol. 75: 415-424.
10. PETRICOIN, E., J. WULFKUHLE, V. ESPINA, et al. 2004. Clinical proteomics: revolutionizing disease detection and patient tailoring therapy. J. Proteome. Res. 3: 209-217.
11. ISSAQ, H.J., T.P. CONRADS, D.A. PRIETO, et al. 2003. SELDI-TOF MS for diagnostic proteomics. Anal. Chem. 75: 148A-155A.
12. CUTLER, P. 2003. Protein arrays: the current state-of-the-art. Proteomics 3: 3-18.
13. MERRICK, B.A. & J.H. MADENSPACHER. 2005. Complementary gene and protein expression studies and integrative approaches in toxicogenomics. Toxicol. Appl. Pharmacol. 207: 189-194.
14. KMIEC, Z. 2001. Cooperation of liver cells in health and disease. Adv. Anat. Embryol. Cell. Biol. 161: III-XIII, 1-151.
15. IIDA, M., C.H. ANNA, J. HARTIS, et al. 2003. Changes in global gene and protein expression during early mouse liver carcinogenesis induced by non-genotoxic model carcinogens oxazepam and Wyeth-14,643. Carcinogenesis 24: 757-770.
16. HEINLOTH, A.N., R.D. IRWIN, G.A. BOORMAN, et al. 2004. Gene expression profiling of rat livers reveals indicators of potential adverse effects. Toxicol. Sci. 80: 193-202.
17. FOSTEL, J., D. CHOI, C. ZWICKL, et al. 2005. Chemical effects in biological systems - data dictionary (CEBS-DD): A compendium of terms for the capture and integration of biological study design description, conventional phenotypes and omics data. Toxicol. Sci. 88: 585-601.
18. PAULES, R. 2003. Phenotypic anchoring: linking cause and effect. Environ. Health Perspect. 111: A338-A339.
19. BRUNO, M.E., C.H. BORCHERS, J.M. DIAL, et al. 2002. Effects of TCDD upon IkappaB and IKK subunits localized in microsomes by proteomics. Arch. Biochem. Biophys. 406: 153-164.
20. MERRICK, B.A. & K.B. TOMER. 2003. Toxicoproteomics: a parallel approach to identifying biomarkers. Environ. Health Perspect. 111: A578-A579.
21. MARKIEWSKI, M.M., R.A. DEANGELIS & J.D. LAMBRIS. 2006. Liver inflammation and regeneration: two distinct biological phenomena or parallel pathophysiologic processes? Mol. Immunol. 43: 45-56.
22. FANNIN, R.D., J.T. AUMAN, M.E. BRUNO, et al. 2005. Differential gene expression profiling in whole blood during acute systemic inflammation in lipopolysaccharide-treated rats. Physiol. Genom. 21: 92-104.
23. VERMEULEN, R., Q. LAN, L. ZHANG, et al. 2005. Decreased levels of CXC-chemokines in serum of benzene-exposed workers identified by array-based proteomics. Proc. Natl. Acad. Sci. USA 102: 17041-17046.